Literature DB >> 18983435

Salivary histatin-5 and oral fungal colonisation in HIV+ individuals.

Sandra R Torres1, Alfredo Garzino-Demo, Timothy F Meiller, Valli Meeks, Mary Ann Jabra-Rizk.   

Abstract

The oral cavity is a primary target for opportunistic infections, particularly oral candidiasis caused by the opportunistic pathogen Candida albicans. HIV+ individuals constitute a population highly susceptible to oral candidiasis possibly due to a change in the environment of the oral cavity as the result of salivary gland dysfunction. Histatins are a family of salivary antimicrobial peptides which under normal circumstances have a protective function on the oral mucosa. This study aimed to compare salivary histatin concentrations and oral fungal colonisation in an HIV+ and HIV- control populations. Oral samples for fungal cultures and parotid saliva were collected from all subjects. Fungal identification was determined using standard mycological procedures. In order to determine salivary histatin levels a semi-quantitative ELISA was designed using a specific polyclonal antibody and extensive statistical analysis was performed. Forty-seven percent of HIV+ and 17% of control subjects had positive fungal cultures. Mean histatin levels were 7.32 microg ml(-1) for the HIV+ group and 9.17 microg ml(-1) for control group (P = 0.003). The data from this study demonstrate that the level of fungal colonisation is significantly higher in HIV+ individuals whereas histatin-5 concentrations are significantly lower, likely contributing to the enhanced predisposition of this population to oral candidiasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983435     DOI: 10.1111/j.1439-0507.2008.01602.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  10 in total

1.  Innate immunity including epithelial and nonspecific host factors: workshop 1B.

Authors:  A Weinberg; J R Naglik; A Kohli; S M Tugizov; P L Fidel; Y Liu; M Herzberg
Journal:  Adv Dent Res       Date:  2011-04

2.  Stability and resilience of oral microcosms toward acidification and Candida outgrowth by arginine supplementation.

Authors:  Jessica E Koopman; Wilfred F M Röling; Mark J Buijs; Christopher H Sissons; Jacob M ten Cate; Bart J F Keijser; Wim Crielaard; Egija Zaura
Journal:  Microb Ecol       Date:  2014-11-30       Impact factor: 4.552

3.  Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection.

Authors:  Brian M Peters; Jingsong Zhu; Paul L Fidel; Mark A Scheper; William Hackett; Sara El Shaye; Mary Ann Jabra-Rizk
Journal:  FEMS Yeast Res       Date:  2010-04-13       Impact factor: 2.796

4.  Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals.

Authors:  Shariq A Khan; Paul L Fidel; Awdah Al Thunayyan; Sharon Varlotta; Timothy F Meiller; Mary Ann Jabra-Rizk
Journal:  J AIDS Clin Res       Date:  2013-03-05

5.  The novel Candida albicans transporter Dur31 Is a multi-stage pathogenicity factor.

Authors:  François L Mayer; Duncan Wilson; Ilse D Jacobsen; Pedro Miramón; Katharina Große; Bernhard Hube
Journal:  PLoS Pathog       Date:  2012-03-15       Impact factor: 6.823

Review 6.  Endogenous antimicrobial factors in the treatment of infectious diseases.

Authors:  Paulina Żelechowska; Justyna Agier; Ewa Brzezińska-Błaszczyk
Journal:  Cent Eur J Immunol       Date:  2017-01-24       Impact factor: 2.085

7.  Evidence of an increased pathogenic footprint in the lingual microbiome of untreated HIV infected patients.

Authors:  Angeline T Dang; Sean Cotton; Sumathi Sankaran-Walters; Chin-Shang Li; Chia-Yuan Michael Lee; Satya Dandekar; Bruce J Paster; Michael D George
Journal:  BMC Microbiol       Date:  2012-07-28       Impact factor: 3.605

8.  A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide.

Authors:  Timothy F Meiller; Bernhard Hube; Lydia Schild; Mark E Shirtliff; Mark A Scheper; Robert Winkler; Amy Ton; Mary Ann Jabra-Rizk
Journal:  PLoS One       Date:  2009-04-07       Impact factor: 3.240

Review 9.  Evaluation of human body fluids for the diagnosis of fungal infections.

Authors:  Parisa Badiee
Journal:  Biomed Res Int       Date:  2013-08-01       Impact factor: 3.411

10.  Specific metallo-protein interactions and antimicrobial activity in Histatin-5, an intrinsically disordered salivary peptide.

Authors:  Tyler G McCaslin; Cynthia V Pagba; Jiby Yohannan; Bridgette A Barry
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.